Abstract Library

#2124 A Case Report of a Malignant Insulinoma

Introduction: Despite rare (1-2% of pancreatic tumors/PT), insulinomas are the most common functional pNET. The diagnosis is established by demonstrating inappropriately high serum insulin levels during a spontaneous or induced episode of hypoglycemia.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Zoumblios C, Tegos T, Kyriakopoulos G, Argyrakos T, Alevizopoulos N,

Keywords: malignant, insulinoma,

#1161 Comparative Proteomic Analysis of Human Insulinoma and Its Clinical Implications in Pancreatic Neuroendocrine Tumors

Introduction: Insulinoma is the most common functional PNET. Its molecular tumorigenesis is largely unknown and proteomic study on insulinoma has not been reported

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Qiao X

Authors: Qiao X, Song Y, Bai C, Zhu L, Lu C,

Keywords: proteomics, pnet, UCH-L1, α-internexin, prognosis ,

#502 Bifunctional ShRNAimPDX-1 Therapy Prevents Hypoglycemic Death From Insulinoma in Mice

Introduction: PDX-1 is a novel molecular target for insulinoma. Bi-functional shRNAi platform has been developed that results in a more effective targeted gene knockdown.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Liu S, Wang Z, Shahi K, Rao D, Zhou G,

Keywords: PDX-1, bi-shRNAi, insulinoma, target,